Gurgaon Samachar

Mydriasis Market: Industry Analysis, Symptoms, Treatment, Drugs and Key Companies by Delveinsight |Théa Laboratories, Omeros Corporation, Ocuphire Pharma and Others

 Breaking News
  • No posts were found

Mydriasis Market: Industry Analysis, Symptoms, Treatment, Drugs and Key Companies by Delveinsight |Théa Laboratories, Omeros Corporation, Ocuphire Pharma and Others

May 31
14:21 2021
Mydriasis Market: Industry Analysis, Symptoms, Treatment, Drugs and Key Companies by Delveinsight |Théa Laboratories, Omeros Corporation, Ocuphire Pharma and Others

Mydriasis Market

DelveInsight’s ‘Mydriasis Market Insights, Epidemiology, and Market Forecast—2030’ report deliver an in-depth understanding of the Mydriasis, historical and forecasted epidemiology as well as the market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.

 

Some of Mydriasis Market Report facts are:

  • The market size of mydriasis is anticipated to be USD 174 million in 2020 during the study period, 2018–2030.
  • Among the European 5 countries, Spain had the lowest number of cases as 0.36 million procedures in 2020.
  • Japan had 0.47 million prevalent cases in 2020 which is expected to increase by 2030.
  • In 2020, cataract surgeries numbers in the US varied according to gender; such as 2.20 million and 1.46 million procedures for females and males, respectively.

 

Request for Free Sample Report: https://www.delveinsight.com/sample-request/mydriasis-market

 

Some of Mydriasis Companies are:

  • Théa Laboratories
  • Omeros Corporation
  • Ocuphire Pharma
  • And Many Others

 

Mydriasis is the dilation of the pupil, which may be due to a non-physiological cause such as disease, trauma, drug usage, or physiological pupillary response. A mydriatic is an agent that induces dilation of the pupil; it is routinely used to aid examination of the retina and other deep structures of the eye. In general medical practice, the most frequent indication for pupil dilation is in the screening of diabetic retinopathy followed by macular degeneration.

This condition can be a symptom of an injury to the brain from physical trauma or a stroke and can affect one pupil at a time or both at once. The pupillary dilation pathway is controlled by the iris dilator muscle, which consists of fibers that are oriented radially, and connect the exterior of the iris with the interior. When the dilator muscle contracts, it pulls the interior of the iris outward, thus increasing the size of the pupil. Furthermore, the iris dilator muscle is controlled by the sympathetic nervous system, the part of the autonomic nervous system that is involved in arousal, wakefulness, and the fight or flight response.

 

Request for Free Sample Report: https://www.delveinsight.com/sample-request/mydriasis-market

 

Some of Mydriasis Therapies are:

  • Mydrane
  • OMIDRIA
  • Mydriasert
  • Nyxol
  • And Many Others

 

Scope of the Mydriasis Report:

  • The report covers the descriptive overview of mydriasis, explaining its causes, signs and symptoms, physiology and currently available therapies
  • Comprehensive insight has been provided into the Mydriasis epidemiology and treatment in the 7MM
  • Additionally, an all-inclusive account of both the current and emerging therapies for mydriasis is provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
  • A detailed review of Mydriasis market; historical and forecasted is included in the report, covering drug outreach in the 7MM
  • The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Mydriasis market

 

Request for Free Sample Report: https://www.delveinsight.com/sample-request/mydriasis-market

 

Table of Contents:

1 Key Insights

2 Executive summary

3 Organizations

4 Epidemiology and Market Methodology

5 Mydriasis: Market Overview at a Glance

6 Mydriasis: Market Overview at a Glance

7 Epidemiology and Patient Population

8 Achieving Mydriasis

9 Unmet Needs

10 Marketed drugs

10.1 Mydrane: Théa Laboratories

10.2 Mydriasert: Théa Laboratories

10.3 OMIDRIA: Omeros Corporation

11 Emerging Therapies

11.2 Nyxol: Ocuphire Pharma

12 Mydriasis: Seven Major Market Analysis

13 Seven Major Market Outlook

14 United States Market Size

15 Market Drivers

16 Market Barriers

17 SWOT Analysis

18 Reimbursement policies

19 Case Study

20 KOL Views

21 Appendix

22 DelveInsight Capabilities

23 Disclaimer

24 About DelveInsight

25 Bibliography

Request for Detailed TOC: https://www.delveinsight.com/sample-request/mydriasis-market

 

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.  Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/report-store/mydriasis-market


Warning: count(): Parameter must be an array or an object that implements Countable in /home/haridwartoday/gurgaon-samachar.com/wp-content/themes/legatus-theme/includes/single/post-tags.php on line 5
Share